19.12.2012 - Swiss drugmaker Roche would still consider buying a gene-sequencing company to fit its strategy of tailoring treatments to specific patients, after dropping a $6.8 billion bid for...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)